Dissolution and Absorption Modeling: Model Expansion to Simulate the Effects of Precipitation, Water Absorption, Longitudinally Changing Intestinal Permeability, and Controlled Release on Drug Absorption

Abstract A previously described model for simulating drug dissolution, absorption, and pharmacokinetics has been expanded beyond the original application of simulating immediate-release dosage forms to include simulation of drug precipitation, water absorption from the gastrointestinal tract, changing gastrointestinal permeability, disintegration, and controlled-release and dissolution from a GITS-type dosage form. A mathematical description of the model is presented as well as a retrospective analysis of nifedipine to demonstrate the utility of the model. The fourth-order Runge-Kutta numerical method was used to solve the series of coupled differential equations used to simulate the process of dissolution, absorption, and drug disposition. The model was able to simulate the clinically demonstrated effect for drug particle size on nifedipine plasma concentrations for an immediate-release dosage form. Further simulations indicated that drug particle size was less important for a GITS-type dosage form at a release rate of 1.7 mg/hr compared to rate of 17 mg/hr. Hypothetical calculations simulated the potential effect of drug precipitation, water absorption, and changing permeability on drug plasma concentrations. The expanded model increases the utility of a previously described model in providing guidance in drug development and selection.

[1]  Kevin C. Johnson,et al.  Dissolution Modeling: Factors Affecting the Dissolution Rates of Polydisperse Powders , 1993, Pharmaceutical Research.

[2]  R. J. Hintz,et al.  The effect of particle size distribution on dissolution rate and oral absorption , 1989 .

[3]  C. Nyström,et al.  Physicochemical aspects of drug release. XV. Investigation of diffusional transport in dissolution of suspended, sparingly soluble drugs , 1992 .

[4]  G. Castañeda-Hernández,et al.  Pharmacokinetics of Oral Nifedipine: Relevance of the Distribution Phase , 1989, Journal of clinical pharmacology.

[5]  Ying Zhang,et al.  Effect of drug particle size on content uniformity of low-dose solid dosage forms , 1997 .

[6]  V. R. Richards,et al.  Nifedipine Kinetics and Bioavailability After Single Intravenous and Oral Doses in Normal Subjects , 1983, Journal of clinical pharmacology.

[7]  M. M. Villiers,et al.  Influence of agglomeration of cohesive particles on the dissolution behaviour of furosemide powder , 1996 .

[8]  M. Gaffney,et al.  Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine. , 1987, The American journal of medicine.

[9]  J. Dressman,et al.  Mixing-tank model for predicting dissolution rate control or oral absorption. , 1986, Journal of pharmaceutical sciences.

[10]  G L Amidon,et al.  Dissolution of acidic and basic compounds from the rotating disk: influence of convective diffusion and reaction. , 1986, Journal of pharmaceutical sciences.

[11]  D. Swanson,et al.  Nifedipine gastrointestinal therapeutic system. , 1987, The American journal of medicine.